Solvonis Therapeutics plc
SVNS.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £1,719 | £757 | £27 | £155 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £115 | £0 | £44 | £71 |
| Inventory | £0 | £0 | £0 | £51 |
| Other Curr. Assets | £0 | £58 | £0 | £43 |
| Total Curr. Assets | £1,834 | £815 | £71 | £314 |
| Property Plant & Equip (Net) | £0 | £0 | £0 | £39 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £0 | £0 | £2,068 | £2,068 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £0 | £0 | £0 | £0 |
| Other NC Assets | £0 | £300 | £0 | £13 |
| Total NC Assets | £7,710 | £2,388 | £2,068 | £2,120 |
| Other Assets | £1 | £0 | £0 | £0 |
| Total Assets | £9,545 | £3,203 | £2,139 | £2,434 |
| Liabilities | – | – | – | – |
| Payables | £1,551 | £83 | £220 | £159 |
| Short-Term Debt | £77 | £0 | £264 | £12 |
| Tax Payable | £0 | £0 | £0 | £22 |
| Deferred Revenue | £0 | £0 | £0 | £93 |
| Other Curr. Liab. | £2 | £36 | £0 | £193 |
| Total Curr. Liab. | £1,630 | £119 | £484 | £386 |
| LT Debt | £0 | £0 | £0 | £22 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £980 | £0 | £0 | £0 |
| Total NC Liab. | £980 | £0 | £0 | £22 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £0 | £0 | £0 | £34 |
| Total Liabilities | £2,610 | £119 | £484 | £408 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £5,846 | £2,233 | £62 | £41 |
| Retained Earnings | -£12,176 | -£10,555 | -£9,591 | -£8,965 |
| AOCI | £0 | £0 | £4,091 | £3,949 |
| Other Equity | £13,265 | £11,406 | £7,093 | £7,001 |
| Total Equity | £6,935 | £3,084 | £1,655 | £2,026 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £9,545 | £3,203 | £2,139 | £2,434 |
| Net Debt | -£1,642 | -£757 | £237 | -£121 |